白藜芦醇的生物活性研究进展

被引:30
作者
史丽 [1 ]
刘燕 [2 ]
许现辉 [3 ]
机构
[1] 天津市脐带血造血干细胞库
[2] 河北医科大学第三医院实验中心
[3] 中国医学科学院中国协和医科大学血液学研究所血液病医院
关键词
白藜芦醇; 生物学活性; 生理功能;
D O I
暂无
中图分类号
R285 [中药药理学];
学科分类号
摘要
从白藜芦醇的来源、一般特性、合成、体内的代谢及生理功能等方面综述了白藜芦醇生物学活性的研究进展。
引用
收藏
页码:5 / 8
页数:4
相关论文
共 20 条
  • [1] Resveratrol inhibits cell cycle pro-gression in U937 cells. Castello L,Tessitore L. Oncology Reports . 2005
  • [2] The daily oraladministration of high doses of trans-resveratrol to ratsfor 28 days is not harmful. Juan M E,Vinardell M P,Planas J M. The Journal of Nutrition . 2002
  • [3] Resveratrol-inducedcellular apoptosis and cell cycle arrest in neuroblastomacells and antitumor effects on neuroblastoma in mice. Chen Y,Tseng S H,Lai H S,et al. Journal of Surgery . 2004
  • [4] Suppression of7,12-dimethylbenz(a)anth racene-induced mammary car-cinogenesis in rats by resveratrol:role of nuclear factor-kappaB,cyclooxygenase 2,and mat-rix metalloprotease 9. Banerjee S,Bueso-Ramos C,Aggarwal B B. Cancer Research . 2002
  • [5] Piceatannol,a stilbene phytochemical,inhibits mitochondrial F0F1-ATPase activity by targetingthe F1 complex. Zheng J,Ramirez V D. Biochemical and Biophysical Research Communications . 1999
  • [6] Phytoalexinresveratrol(3-4’-5-trihydroxystilbene)modulates granu-locyte and monocyte endothelial adhesion. Ferrero M E,Bertelli A A,Pellegatta F,et al. Transplantation Proceedings . 1998
  • [7] Resveratrol inducesapoptosis in thyroid cancer cell lines via a MAPK-and-p53-dependent mechanism. Shih A,Davis F B,Lin H Y,et al. The Journal of Clinical Endocrinology . 2002
  • [8] p-Coumaroyltriaceticacid synthase,a new homologue of chalcone synthase,fromHydrangea macrophylla var thunbergii. Akiyama T,Shibuya M,Liu H M,et al. European Journal of Biochemistry . 1999
  • [9] Reaction mechanismsof homodimeric plant polyketidesynthases(stilbene andchalcone synthase). Tropf S,Karcher B,Schrodre G,et al. Journal of Biological Chemistry . 1995
  • [10] Resveratrol regulates cellular PKC α and δ to inhibit growth and induce apoptosis in gastric cancer cells
    Atten, MJ
    Godoy-Romero, E
    Attar, BM
    Milson, T
    Zopel, M
    Holian, O
    [J]. INVESTIGATIONAL NEW DRUGS, 2005, 23 (02) : 111 - 119